Is There an Expanded Role for Digoxin in Patients with Heart Failure and Sinus Rhythm? A Protagonist Viewpoint

Parmley WW Smith TW Pitt B . Should digoxin be the drug of first choice after diuretics in chronic congestive heart failure? J Am Coll Cardiol 1988; 12:265–73.

Van Veldhuisen DJ De Graeff PA Remme WJ Lie KI . Value of digoxin in heart failure and sinus rhythm: New features of an old drug? J Am Coll Cardiol 1996; 28:813–9.

Jaeschke R Oxman AD Guyatt GH . To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. Am J Med 1990; 88:279–86.

The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316:1429–35.

Cohn JN Johnson G Ziesche S Cobb F Francis G Tristani F . A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 1991; 325:303–10.

The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685–91.

Konstam MA Dracup K Baker DW Bottorff MB Brooks NH Dacey RA , Heart failure: Evaluation and care of patients with left-ventricular systolic dysfunction. Clinical practice guideline 11. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994.

Williamson KM . Is there a role for digoxin in patients with systolic dysfunction? Pharmacotherapy 1996; 16 (2 pt 2):37S–42S.

Uretsky BF Young JB Shahidi FE Yellen LG Harrison MC Jolly MK . Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial. J Am Coll Cardiol 1993; 22:955–62.

Packer M Gheorghiade M Young JB Costantini PJ Adams KF Cody RJ , Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med 1993; 329:1–7.

Poole-Wilson PA . Digoxin withdrawal in patients with heart failure (letter). J Am Coll Cardiol 1994; 24:578.

Uretsky BF Young JB Jolly MK . Digoxin withdrawal in patients with heart failure (letter). J Am Coll Cardiol 1994; 24:578–9.

Gorlin R Garg R . The effect of digitalis on mortality and hospitalization in patients with heart-failure. Presented at the 45th Annual Scientific Session, American College of Cardiology, Orlando, FL, March 26, 1996.

Yusuf S Garg R Smith T Dagenais G Montague T Arnold M , Which heart failure patients benefit the most from long term digoxin therapy (abstract)? Circulation 1996; 94(suppl):I–23.

Garg R Gorlin R Smith T , Yusuf S, for The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336:525–33.

Packer M Carver JR Rodeheffer RJ Ivanhoe RJ DiBianco R Zeldis SM , Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325:1468–75.

Packer M . How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 1993; 71(suppl):3C–11C.

Francis GS . The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J 1989; 118:642–7.

Cohn JN Levine TB Olivari MT Garberg V Lura D Francis GS , Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819–23.

Waagstein F Bristow MR Swedberg K Camerini F Fowler MB Silver MA , Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342:1441–6.

Packer M Bristow MR Cohn JN Colucci WS Fowler MB Gilbert EM , The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334:1349–55.

Arnold SB Byrd RC Meister W Melmon K Cheitlin MD Bristow JD , Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 1980; 303:1443–8.

Gheorghiade M St Clair J St Clair C Beller GA . Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 1987; 9:849–57.

Califf RM Adams KF Armstrong PW Darius H Gheorghiade M Handberg E , Flolan International Randomized Survival Trial (FIRST): Final results (abstract). J Am Coll Cardiol 1995; 27(suppl):141A.

Krell MJ Kline EM Bates ER Hodgson JMB Dilworth LR Laufer N , Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J 1986; 112:787–91.

Gheorghiade M Ferguson D . Digoxin: A neurohormonal modulator in heart failure? Circulation 1991; 84:2181–6.

Ferguson DW Berg WJ Sanders JS Roach PJ Kempf JS Kienzle MG . Sympathoinhibitory responses to digitalis glycosides in heart failure patients — Direct evidence from sympathetic neural recordings. Circulation 1989; 80:65–77.

Ribner HS Plucinski DA Hsieh AM Bresnahan D Molteni A Askenazi J , Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic–hormonal study. Am J Cardiol 1985; 56:896–904.

Krum H Bigger JT Goldsmith R Packer M . Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995; 25:289–94.

Van Veldhuisen DJ Man In't Veld AJ Dunselman PHJM Lok DJA Dohmen HJM Poortermans JC , Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: Results of the Dutch ibopamine multicenter trial (DIMT). J Am Coll Cardiol 1993; 22:1564–73.

Malik M Camm AJ Bigger JT Breithardt G Cerutti S Cohen RJ . Heart rate variability standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93:1043–65.

Clarke JM Hamer J Shelton JR Taylor S . The rhythm of the normal heart. Lancet 1976;2508–12.

Casolo G Balli E Taddei T Amuhasi J Gori C . Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989; 64:1162–7.

Panina G Khot UN Nunziata E Cody RJ Binkley PF . Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors. Am Heart J 1996; 131:153–7.

Ponikowski P Anker SD Amadi A Chua TP Cerquetani E Ondusova D , Heart rhythms, ventricular arrhythmias, and death in chronic heart failure. J Card Failure 1996; 2:177–83.

Flapan AD Nolan J Neilson JMM Ewing DJ . Effect of captopril on parasympathetic activity in chronic cardiac failure secondary to coronary artery disease. Am J Cardiol 1992; 69:532–5.

Kaufman ES Bosner MS Bigger JT Stein PK Kleiger RE Rolnitzky LM , Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects. Am J Cardiol 1993; 72:95–9.

Brouwer J Van Veldhuisen DJ Man In't Veld AJ Dunselman PHJM Boomsma F Haaksma J , Heart rate variability in patients with mild to moderate heart failure: Effects of neurohormonal modulation by digoxin and ibopamine. J Am Coll Cardiol 1995; 26:983–90.

Gheorghiade M Hall V Jacobsen G Alam M Rosman H Goldstein S . Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation 1995; 92:1801–7.

Young JB Gheorghiade M Packer M Uretsky B Hull H . Are low serum levels of digoxin effective in chronic heart failure? Evidence challenging the accepted guidelines for a therapeutic serum level of the drug (abstract). J Am Coll Cardiol 1993; 21:378A.

Kleber FX Thyroff-Friesinger U . Ibopamine versus digoxin in the treatment of mild congestive heart failure. Cardiology 1990; 77(suppl 5):75–80.

Van Veldhuisen DJ Brouwer J Man In't Veld AJ Dunselman PHJM Boomsma F Lie KI . Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. Am J Cardiol 1995; 75:796–800.

Zoeller J . The top 200 drugs. Am Druggist 1997; 214:30–7.

Ogilvie R Ruedy J . Adverse drug reactions during hospitalization. Can Med Assoc J 1967; 97:1450–7.

Beller GA Smith TW Abelmann WH Haber E Hood WB . Digitalis intoxication: A prospective clinical study with serum level correlations. N Engl J Med 1971; 284:989–97.

Mahdyoon H Battilana G Rosman H Goldstein S Gheorghiade M . The evolving pattern of digoxin intoxication: Observations at a large urban hospital from 1980 to 1988. Am Heart J 1990; 120:1189–94.

Williamson KM Thrasher KA Fulton KB Allen-LaPointe NM Dunham GD Cooper AA , Frequency of supratherapeutic serum digoxin concentrations and digoxin toxicity (abstract). Pharmacotherapy 1997; 17:184.

Amman EM Wenger TL Butler VP Haber E Smith TW . Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: Final report of a multicenter study. Circulation 1990; 81:1744–52.

Ikram H Chan W Espiner EA Nicholls MG . Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci 1980; 59:443–9.

Packer M Gottlieb SS Kessler PD . Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Am J Med 1986; 80(suppl 4A):23–9.

Ward RE Gheorghiade M Young JB Uretsky B . Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol 1995; 26:93–101.